Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Community pharmacist-provided opioid intervention frequencies and barriers.
Nichols MA, Kepley KL, Rosko KS, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Nichols MA, et al. Among authors: ott ca. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):336-342. doi: 10.1016/j.japh.2022.10.004. Epub 2022 Oct 14. J Am Pharm Assoc (2003). 2023. PMID: 36369075 Free PMC article.
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death.
Rosenbaum SR, Caksa S, Stefanski CD, Trachtenberg IV, Wilson HP, Wilski NA, Ott CA, Purwin TJ, Haj JI, Pomante D, Kotas D, Chervoneva I, Capparelli C, Aplin AE. Rosenbaum SR, et al. Among authors: ott ca. Mol Cancer Res. 2024 Feb 1;22(2):209-220. doi: 10.1158/1541-7786.MCR-23-0290. Mol Cancer Res. 2024. PMID: 37847239
Targeting TEAD-ious resistance.
Ott CA, Aplin AE. Ott CA, et al. Trends Cancer. 2023 Oct;9(10):780-781. doi: 10.1016/j.trecan.2023.07.016. Epub 2023 Aug 3. Trends Cancer. 2023. PMID: 37543514
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma.
Glasheen MQ, Caksa S, Young AG, Wilski NA, Ott CA, Chervoneva I, Flaherty KT, Herlyn M, Xu X, Aplin AE, Capparelli C. Glasheen MQ, et al. Among authors: ott ca. Mol Cancer Ther. 2023 Sep 5;22(9):1087-1099. doi: 10.1158/1535-7163.MCT-23-0025. Mol Cancer Ther. 2023. PMID: 37343247 Free PMC article.
Differential recognition of canonical NF-κB dimers by Importin α3.
Florio TJ, Lokareddy RK, Yeggoni DP, Sankhala RS, Ott CA, Gillilan RE, Cingolani G. Florio TJ, et al. Among authors: ott ca. Nat Commun. 2022 Mar 8;13(1):1207. doi: 10.1038/s41467-022-28846-z. Nat Commun. 2022. PMID: 35260573 Free PMC article.
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disorders.
Pagliaroli L, Porazzi P, Curtis AT, Scopa C, Mikkers HMM, Freund C, Daxinger L, Deliard S, Welsh SA, Offley S, Ott CA, Calabretta B, Brugmann SA, Santen GWE, Trizzino M. Pagliaroli L, et al. Among authors: ott ca. Nat Commun. 2021 Nov 9;12(1):6469. doi: 10.1038/s41467-021-26810-x. Nat Commun. 2021. PMID: 34753942 Free PMC article.
32 results